by Clare Gerrard | Mar 16, 2023
Kate Quirk, Neuroendocrine Cancer UK Patient Support Coordinator, has just been appointed to the INCA Research Committee, after contributing to the completion of a project to bring wider access to Clinical Trials for Neuroendocrine Cancer patients globally. INCA (the... by Clare Gerrard | Mar 14, 2023
Neuroendocrine Cancers – A “NET” Update from Prof. Mark Strachan Wednesday 12th April 2023 13:30pm – 15:30pm Liberton Kirk Centre, Kirkgate, Liberton, Edinburgh, EH16 6RY Professor Strachan will be giving an update on the treatment and administration of... by Clare Gerrard | Feb 7, 2023
One Cancer Voice – Petition to the Prime Minister to demand the UK Government keeps its commitment to transform cancer care and services. In a speech at the Francis Crick Institute on World Cancer Day 2022 (4 February), the then Health and Social Care Secretary,... by Clare Gerrard | Jan 30, 2023
In medicine, the term “zebra” is used in reference to a rare disease or condition. “If you hear hooves, you assume horse.” The rare disease community wants you to consider zebra. We agree with and advocate this message. However due to the rise in incidence of... by Leanne Talbot | Dec 19, 2022
We are delighted to announce the appointment of our new Trustee, David David is a semi-retired GP and received a diagnosis of Neuroendocrine Cancer in 2016. In his video here, he talks about the symptoms he experienced over a 13-year period before an official... 
